F. Lehmann

1.4k total citations
38 papers, 542 citations indexed

About

F. Lehmann is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, F. Lehmann has authored 38 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 9 papers in Public Health, Environmental and Occupational Health and 9 papers in Immunology. Recurrent topics in F. Lehmann's work include Ovarian function and disorders (10 papers), Reproductive Biology and Fertility (6 papers) and Estrogen and related hormone effects (6 papers). F. Lehmann is often cited by papers focused on Ovarian function and disorders (10 papers), Reproductive Biology and Fertility (6 papers) and Estrogen and related hormone effects (6 papers). F. Lehmann collaborates with scholars based in Germany, Switzerland and United States. F. Lehmann's co-authors include G. Trams, G. Bettendorf, H. Maaß, M. Breckwoldt, P. Czygan, Klaus Diedrich, H.H. van der Ven, Dieter Krebs, Daniela Finke and Robert Ivánek and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

F. Lehmann

36 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Lehmann Germany 13 167 150 130 114 102 38 542
K Matsushita Japan 13 82 0.5× 242 1.6× 133 1.0× 60 0.5× 175 1.7× 28 544
Katsuji Kokawa Japan 16 426 2.6× 287 1.9× 169 1.3× 81 0.7× 227 2.2× 27 920
Hernan F. Acevedo United States 13 98 0.6× 124 0.8× 65 0.5× 95 0.8× 196 1.9× 29 575
M Mochizuki Japan 11 120 0.7× 168 1.1× 307 2.4× 55 0.5× 227 2.2× 14 631
Sharon L. Eddie United Kingdom 12 81 0.5× 169 1.1× 164 1.3× 84 0.7× 179 1.8× 17 469
Jun Xing China 14 141 0.8× 175 1.2× 82 0.6× 65 0.6× 196 1.9× 62 584
Shigetatsu Shiokawa Japan 13 217 1.3× 140 0.9× 102 0.8× 56 0.5× 120 1.2× 18 468
Meerit Kämäräinen Finland 11 282 1.7× 141 0.9× 176 1.4× 62 0.5× 170 1.7× 20 527
Xiaowen Tong China 15 98 0.6× 117 0.8× 89 0.7× 112 1.0× 244 2.4× 35 549
Vivien Grant United Kingdom 13 152 0.9× 80 0.5× 86 0.7× 67 0.6× 343 3.4× 19 686

Countries citing papers authored by F. Lehmann

Since Specialization
Citations

This map shows the geographic impact of F. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lehmann more than expected).

Fields of papers citing papers by F. Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lehmann. The network helps show where F. Lehmann may publish in the future.

Co-authorship network of co-authors of F. Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of F. Lehmann. A scholar is included among the top collaborators of F. Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lehmann. F. Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parmigiani, Elena, Robert Ivánek, Chiara Rolando, et al.. (2022). Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells. Developmental Cell. 57(15). 1847–1865.e9. 26 indexed citations
2.
Lehmann, F., Elias Hobeika, Berit Jungnickel, et al.. (2021). ERK phosphorylation is RAF independent in naïve and activated B cells but RAF dependent in plasma cell differentiation. Science Signaling. 14(682). 4 indexed citations
3.
Horváth, Edit, Caner Ercan, Salvatore Piscuoglio, et al.. (2021). mTOR signaling mediates ILC3-driven immunopathology. Mucosal Immunology. 14(6). 1323–1334. 14 indexed citations
4.
Lehmann, F., Nicole von Burg, Robert Ivánek, et al.. (2020). Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation. Nature Communications. 11(1). 1794–1794. 50 indexed citations
5.
Dietzel, Frederic, Michael Karl Boettger, Katja Dahlke, et al.. (2013). Assessment of Rat Antigen-Induced Arthritis and Its Suppression During Glucocorticoid Therapy by Use of Hemicyanine Dye Probes With Different Molecular Weight in Near-Infrared Fluorescence Optical Imaging. Investigative Radiology. 48(10). 729–737. 5 indexed citations
6.
Kammertoens, Thomas, F. Lehmann, Andrea Wilke, et al.. (2013). Targeting c-MYC with T-Cells. PLoS ONE. 8(10). e77375–e77375. 10 indexed citations
7.
Haedicke, Katja, Susanna Gräfe, F. Lehmann, & Ingrid Hilger. (2013). Multiplexed in vivo fluorescence optical imaging of the therapeutic efficacy of photodynamic therapy. Biomaterials. 34(38). 10075–10083. 15 indexed citations
8.
Lehmann, F., Ursula Zimber‐Strobl, Ralf Kühn, et al.. (2012). Humanized c-Myc Mouse. PLoS ONE. 7(7). e42021–e42021. 4 indexed citations
9.
Gerbitz, Armin, Madhusudhanan Sukumar, Andrea Wilke, et al.. (2012). Stromal Interferon-γ Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice. PLoS ONE. 7(3). e34552–e34552. 12 indexed citations
10.
Lehmann, F., et al.. (2006). Diagnosis of peritonitis using near-infrared optical imaging of in vivo labeled monocytes-macrophages. Journal of Biomedical Optics. 11(6). 64014–64014. 9 indexed citations
11.
Hainaut, Pierre, F. Lehmann, Francis Zech, et al.. (1997). Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. Journal of Internal Medicine. 241(5). 427–433. 11 indexed citations
12.
Lehmann, F., et al.. (1988). Ovarian stimulation for in-vitro fertilization: clomiphene and HMG. Human Reproduction. 3(suppl 2). 11–21. 8 indexed citations
13.
Hasani, Saeed, et al.. (1983). Ovarielle Stimulation in einem In-vitro-Fertilisationsprogramm. Geburtshilfe und Frauenheilkunde. 43(8). 486–489. 9 indexed citations
14.
Zimmermann, R., et al.. (1982). Gonadotropin Therapy of Female Infertility. Gynecologic and Obstetric Investigation. 14(1). 1–18. 24 indexed citations
15.
Diedrich, K., Freimut A. Leidenberger, F. Lehmann, & G. Bettendorf. (1978). [Clinical experimental studies in the treatment of ovarian dysfunction with bromo-ergocryptin (pravidel) (author's transl)].. PubMed. 38(9). 716–25. 2 indexed citations
16.
Willig, R. P. & F. Lehmann. (1978). Evaluation of a Gonadal Stimulation Test in Children with Pseudohermaphroditism. Pediatric Research. 12(11). 1094–1094. 1 indexed citations
17.
Masson, Dominique, et al.. (1976). Blastoid transformation of lymphocytes in response to spermatozoa.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 21(3). 171–6. 4 indexed citations
18.
Breckwoldt, M., P. Czygan, F. Lehmann, & G. Bettendorf. (1974). SYNTHETIC LH-RH AS A THERAPEUTIC AGENT. European Journal of Endocrinology. 75(2). 209–220. 20 indexed citations
19.
Trams, G., et al.. (1973). SPECIFIC BINDING OF OESTRADIOL IN HUMAN UTERINE TISSUE. European Journal of Endocrinology. 72(2). 351–360. 35 indexed citations
20.
Masson, Dominique, F. Lehmann, M. Breckwoldt, & D. Krebs. (1970). [Spermatic antibodies as a possible cause of undetermined sterility].. PubMed. 30(2). 103–16. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Matsushita Breakdown of academic impact, for papers by Katsuji Kokawa Breakdown of academic impact, for papers by Hernan F. Acevedo Breakdown of academic impact, for papers by M Mochizuki Breakdown of academic impact, for papers by Sharon L. Eddie Breakdown of academic impact, for papers by Jun Xing Breakdown of academic impact, for papers by Shigetatsu Shiokawa Breakdown of academic impact, for papers by Meerit Kämäräinen Breakdown of academic impact, for papers by Xiaowen Tong Breakdown of academic impact, for papers by Vivien Grant
Rankless by CCL
2026